The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Antimicrobial resistance: Prevalence, economic burden, mechanisms of resistance and strategies to overcome
Open accessAbstract
Antibiotic resistance is a major health concern globally and has been estimated to cause 10 million deaths worldwide by year 2050 if the current trend of inappropriate and excessive use of antibiotics continues. Although, the discovery of antibiotics has saved countless of lives for the past 80 years, increasing levels of bacterial resistance to antibiotics would jeopardize the progress in clinical and agricultural sectors and may cause life-threatening situations even for previously treatable bacterial infections. Antibiotic resistance would increase the levels of poverty of low-middle income countries mostly due to extended hospital stays, higher cost of treatment and untimely deaths that directly affect the total productivity rate. Recent incidences of antibiotic resistance have been gradually increasing globally and this may potentiate horizontal transmission of the resistant gene and have been linked with cross-resistance to other antibiotic families as well. This review summarizes the global burden of antibiotic resistance from the economic viewpoint, highlights the recent incidences of antibiotic resistance mainly related to Escherichia coli, Acinetobacter baumannii, Klebsiella pneumoniae, Salmonella spp. and Staphylococcus aureus, describes the common mechanistic actions of antibiotic resistance and potential strategies to overcome antibiotic resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
Origins and evolution of antibiotic resistance
Davies, J., & Davies, D. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00016-10 · Cited by 5,784
The antibiotic resistance crisis: part 1: causes and threats.
Ventola, C. L. (2015) · PubMed · Cited by 4,516
Molecular mechanisms of antibiotic resistance
Blair, J. M. A., Webber, M. A., Baylay, A. J., Ogbolu, D. O., & Piddock, L. J. V. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3380 · Cited by 4,092
Antibacterial resistance worldwide: causes, challenges and responses
Levy, S. B., & Marshall, B. (2004) · Nature Medicine · doi:10.1038/nm1145 · Cited by 4,052
Global trends in antimicrobial use in food animals
Van Boeckel, T. P., Brower, C., Gilbert, M., Grenfell, B. T., Levin, S. A., Robinson, T. P., Teillant, A., & Laxminarayan, R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1503141112 · Cited by 3,973
Mechanisms of Antibiotic Resistance
Munita, J. M., & Arias, C. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0016-2015 · Cited by 2,782
How antibiotics kill bacteria: from targets to networks
Kohanski, M. A., Dwyer, D. J., & Collins, J. J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2333 · Cited by 2,258
Lister, P. D., Wolter, D. J., & Hanson, N. D. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00040-09 · Cited by 1,789
Inactivation of Antibiotics and the Dissemination of Resistance Genes
Davies, J. (1994) · Science · doi:10.1126/science.8153624 · Cited by 1,730
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050?
de Kraker, M. E. A., Stewardson, A. J., & Harbarth, S. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002184 · Cited by 1,596
High Frequency of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Lung Infection
Oliver, A., Cantón, R., Campo, P., Baquero, F., & Blázquez, J. (2000) · Science · doi:10.1126/science.288.5469.1251 · Cited by 1,465
Antimicrobial resistance: the example of Staphylococcus aureus
Lowy, F. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18535 · Cited by 1,445
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients
Smith, E. E., Buckley, D. G., Wu, Z., Saenphimmachak, C., Hoffman, L. R., D’Argenio, D. A., Miller, S. I., Ramsey, B. W., Speert, D. P., Moskowitz, S. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602138103 · Cited by 1,319
Beceiro, A., Tomás, M., & Bou, G. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00059-12 · Cited by 1,070
Antibacterial peptides for therapeutic use: obstacles and realistic outlook
MARR, A., GOODERHAM, W., & HANCOCK, R. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.04.006 · Cited by 1,051
Efflux-Mediated Drug Resistance in Bacteria: An Update
Li, X.-Z., & Nikaido, H. (2009) · Drugs · doi:10.2165/11317030-000000000-00000 · Cited by 966
Bacterial resistance to antibiotics: Enzymatic degradation and modification
WRIGHT, G. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.04.002 · Cited by 897
Adaptive and Mutational Resistance: Role of Porins and Efflux Pumps in Drug Resistance
Fernández, L., & Hancock, R. E. W. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00043-12 · Cited by 892
Hartman, B. J., & Tomasz, A. (1984) · Journal of Bacteriology · doi:10.1128/jb.158.2.513-516.1984 · Cited by 890
Alternatives to antibiotics—a pipeline portfolio review
Czaplewski, L., Bax, R., Clokie, M., Dawson, M., Fairhead, H., Fischetti, V. A., Foster, S., Gilmore, B. F., Hancock, R. E. W., Harper, D., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00466-1 · Cited by 848
The fitness costs of antibiotic resistance mutations
Melnyk, A. H., Wong, A., & Kassen, R. (2015) · Evolutionary Applications · doi:10.1111/eva.12196 · Cited by 689
Jin, D. J., & Gross, C. A. (1988) · Journal of Molecular Biology · doi:10.1016/0022-2836(88)90517-7 · Cited by 683
Combination approaches to combat multidrug-resistant bacteria
Worthington, R. J., & Melander, C. (2013) · Trends in Biotechnology · doi:10.1016/j.tibtech.2012.12.006 · Cited by 625
Mycobacterial cell wall: Structure and role in natural resistance to antibiotics
Jarlier, V (1994) · FEMS Microbiology Letters · doi:10.1016/0378-1097(94)90267-4 · Cited by 593
Mechanisms of resistance to aminoglycoside antibiotics: overview and perspectives
Garneau-Tsodikova, S., & Labby, K. J. (2016) · MedChemComm · doi:10.1039/c5md00344j · Cited by 576
Estimating the burden of antimicrobial resistance: a systematic literature review
Naylor, N. R., Atun, R., Zhu, N., Kulasabanathan, K., Silva, S., Chatterjee, A., Knight, G. M., & Robotham, J. V. (2018) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-018-0336-y · Cited by 568
Mobile genetic elements of Staphylococcus aureus
Malachowa, N., & DeLeo, F. R. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0389-4 · Cited by 560
Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy
Ejim, L., Farha, M. A., Falconer, S. B., Wildenhain, J., Coombes, B. K., Tyers, M., Brown, E. D., & Wright, G. D. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.559 · Cited by 525
Role of efflux pumps in the antibiotic resistance of bacteria embedded in a biofilm
Soto, S. M. (2013) · Virulence · doi:10.4161/viru.23724 · Cited by 513
Seven Ways to Preserve the Miracle of Antibiotics
Bartlett, J. G., Gilbert, D. N., & Spellberg, B. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit070 · Cited by 468
Strategies to Minimize Antibiotic Resistance
Lee, C.-R., Cho, I., Jeong, B., & Lee, S. (2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10094274 · Cited by 446
Ventre, I., Goodman, A. L., Vallet-Gely, I., Vasseur, P., Soscia, C., Molin, S., Bleves, S., Lazdunski, A., Lory, S., & Filloux, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507407103 · Cited by 428
Resistance of Staphylococcus aureus to the Action of Penicillin.
Rammelkamp, C. H., & Maxon, T. (1942) · Experimental Biology and Medicine · doi:10.3181/00379727-51-13986 · Cited by 416
Evolution of Drug Resistance in Mycobacterium tuberculosis : Clinical and Molecular Perspective
Gillespie, S. H. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.267-274.2002 · Cited by 412
Resistance to rifampicin: a review
Goldstein, B. P. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2014.107 · Cited by 409
Multidrug Resistant and Extensively Drug Resistant Bacteria: A Study
Basak, S., Singh, P., & Rajurkar, M. (2016) · Journal of Pathogens · doi:10.1155/2016/4065603 · Cited by 395
Access to Essential Drugs in Poor Countries: A Lost Battle?
Pécoul, B., Chirac, P., Trouiller, P., & Pinel, J. (1999) · JAMA · doi:10.1001/jama.281.4.361 · Cited by 394
Selective pressure of antibiotic pollution on bacteria of importance to public health
Tello, A., Austin, B., & Telfer, T. C. (2012) · Environmental Health Perspectives · doi:10.1289/ehp.1104650 · Cited by 383
Benefits and risks of antimicrobial use in food-producing animals
Hao, H., Cheng, G., Iqbal, Z., Ai, X., Hussain, H. I., Huang, L., Dai, M., Wang, Y., Liu, Z., & Yuan, Z. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00288 · Cited by 383
Somoskovi, A., Parsons, L. M., & Salfinger, M. (2001) · Respiratory Research · doi:10.1186/rr54 · Cited by 373
Antibiotic Resistance Mechanisms in Bacteria: Biochemical and Genetic Aspects
Kos, B., Džidić, S., & Šušković, J. (2008) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 362
Antibiotic Resistance Mechanisms of Clinically Important Bacteria
Giedraitienė, A., Vitkauskienė, A., Naginienė, R., & Pavilonis, A. (2011) · Medicina · doi:10.3390/medicina47030019 · Cited by 362
Multidrug-Resistant Mycobacterium tuberculosis: Molecular Perspectives
Rattan, A., Kalia, A., & Ahmad, N. (1998) · Emerging Infectious Diseases · doi:10.3201/eid0402.980207 · Cited by 355
Patterns of antibiotic use in global pig production: A systematic review
Lekagul, A., Tangcharoensathien, V., & Yeung, S. (2019) · Veterinary and Animal Science · doi:10.1016/j.vas.2019.100058 · Cited by 352
Tackling antimicrobial resistance in the COVID-19 pandemic
Getahun, H., Smith, I., Trivedi, K., Paulin, S., & Balkhy, H. H. (2020) · Bulletin of the World Health Organization · doi:10.2471/blt.20.268573 · Cited by 325
Baharoglu, Z., Bikard, D., & Mazel, D. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001165 · Cited by 319
Suleyman, G., Alangaden, G., & Bardossy, A. C. (2018) · Current Infectious Disease Reports · doi:10.1007/s11908-018-0620-2 · Cited by 316
Inducible SOS Response System of DNA Repair and Mutagenesis in Escherichia coli
Janion, C. (2008) · International Journal of Biological Sciences · doi:10.7150/ijbs.4.338 · Cited by 303
The SOS response regulates adaptive mutation
McKenzie, G. J., Harris, R. S., Lee, P. L., & Rosenberg, S. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120161797 · Cited by 295
Recover the lost art of drug discovery
Lewis, K. (2012) · Nature · doi:10.1038/485439a · Cited by 276
The Mycobacterial Cell Envelope--Lipids
Jackson, M. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a021105 · Cited by 269
Combination therapies for combating antimicrobial resistance
Fischbach, M. A. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.08.003 · Cited by 259
Ramaswamy, S. V., Amin, A. G., Göksel, S., Stager, C. E., Dou, S.-J., El Sahly, H., Moghazeh, S. L., Kreiswirth, B. N., & Musser, J. M. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.2.326-336.2000 · Cited by 240
mecA Gene Is Widely Disseminated in Staphylococcus aureus Population
Wielders, C. L. C., Fluit, A. C., Brisse, S., Verhoef, J., & Schmitz, F. J. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.11.3970-3975.2002 · Cited by 231
Antimicrobial resistance: more than 70 years of war between humans and bacteria
Nadeem, S. F., Gohar, U. F., Tahir, S. F., Mukhtar, H., Pornpukdeewattana, S., Nukthamna, P., Moula Ali, A. M., Bavisetty, S. C. B., & Massa, S. (2020) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2020.1813687 · Cited by 209
The evolution of a resistant pathogen – the case of MRSA
Enright, M. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00109-7 · Cited by 205
Okano, A., Isley, N. A., & Boger, D. L. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1704125114 · Cited by 199
Q&A: Antibiotic resistance: where does it come from and what can we do about it?
Wright, G. D. (2010) · BMC Biology · doi:10.1186/1741-7007-8-123 · Cited by 195
Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance
Oliver, A., & Mena, A. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03250.x · Cited by 194
Fiamegos, Y. C., Kastritis, P. L., Exarchou, V., Han, H., Bonvin, A. M. J. J., Vervoort, J., Lewis, K., Hamblin, M. R., & Tegos, G. P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018127 · Cited by 190
Rodríguez-Verdugo, A., Gaut, B. S., & Tenaillon, O. (2013) · BMC Evolutionary Biology · doi:10.1186/1471-2148-13-50 · Cited by 168
Pricing infectious disease: The economic and health implications of infectious diseases
Fonkwo, P. N. (2008) · EMBO reports · doi:10.1038/embor.2008.110 · Cited by 161
Labby, K. J., & Garneau‐Tsodikova, S. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.80 · Cited by 154
Ohno, H., Koga, H., KOHNO, S., Tashiro, T., & Hara, K. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.4.1053 · Cited by 149
In vitro activity of ceftazidime+NXL104 against Pseudomonas aeruginosa and other non-fermenters
Mushtaq, S., Warner, M., & Livermore, D. M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq306 · Cited by 129
Diagnostics for Developing Countries
McNerney, R. (2015) · Diagnostics · doi:10.3390/diagnostics5020200 · Cited by 111
Antimicrobial resistance and universal health coverage
Bloom, G., Buckland‐Merrett, G., Wilkinson, A., Lin, V. K.-W., & Paulin, S. (2017) · BMJ Global Health · doi:10.1136/bmjgh-2017-000518 · Cited by 110
Shazely, B. E., Yu, G., Johnston, P. R., & Rolff, J. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00103 · Cited by 108
Levasseur, P., Girard, A.-M., Claudon, M., Goossens, H., Black, M. T., Coleman, K., & Miossec, C. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06064-11 · Cited by 102
Understanding and overcoming antibiotic resistance
Richardson, L. A. (2017) · PLoS Biology · doi:10.1371/journal.pbio.2003775 · Cited by 99
Dhillon, P. K., Jeemon, P., Arora, N. K., Mathur, P., Maskey, M., Sukirna, R. D., & Prabhakaran, D. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dys046 · Cited by 97
Galani, I., Souli, M., Daikos, G. L., Chryssouli, Z., Poulakou, G., Psichogiou, M., Panagea, T., Argyropoulou, A., Stefanou, I., Plakias, G., et al. (2012) · Journal of Chemotherapy · doi:10.1179/1973947812y.0000000015 · Cited by 96
Tompkins, J. D., Nelson, J. L., Hazel, J. C., Leugers, S. L., Stumpf, J. D., & Foster, P. L. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.11.3469-3472.2003 · Cited by 93
Can antibiotic-resistant nosocomial infections be controlled?
Farr, B. M., Salgado, C. D., Karchmer, T. B., et al. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00020-2 · Cited by 85
PK/PD models in antibacterial development
Velkov, T., Bergen, P. J., Lora-Tamayo, J., Landersdorfer, C. B., & Li, J. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.06.010 · Cited by 83
Zhao, L., Sun, Q., Liu, H., Wu, X., Xiao, T., Zhao, X.-Q., Li, G., Jiang, Y., Zeng, C.-Y., & Wan, K. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04933-14 · Cited by 80
COVID-19 drug practices risk antimicrobial resistance evolution
Afshinnekoo, E., Bhattacharya, C., Burguete-García, A. I., Castro‐Nallar, E., Deng, Y., Desnues, C., Dias‐Neto, E., Elhaik, E., Iraola, G., Jang, S., et al. (2021) · The Lancet Microbe · doi:10.1016/s2666-5247(21)00039-2 · Cited by 80
(Inter)nationalising the antibiotic research and development pipeline
Singer, A. C., Kirchhelle, C., & Roberts, A. P. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30552-3 · Cited by 76
Hall, A. R., Iles, J., & MacLean, R. C. (2011) · Genetics · doi:10.1534/genetics.110.124628 · Cited by 69
Ito, T., & Hiramatsu, K. (1998) · Yonsei Medical Journal · doi:10.3349/ymj.1998.39.6.526 · Cited by 66
Escherichia coli Cells Exposed to Streptomycin Display a Mutator Phenotype
Ren, L., Rahman, M. S., & Humayun, M. Z. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.3.1043-1044.1999 · Cited by 64
Pulingam, T., Thong, K. L., Appaturi, J. N., Nordin, N. I., Dinshaw, I. J., Lai, C. W., & Leo, B. F. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.105087 · Cited by 62
Self-citationAntibiotic resistance during and beyond COVID-19
Livermore, D. M. (2021) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlab052 · Cited by 51
Wertheim, H. F. L., Puthavathana, P., Ngoc, N. M., van Doorn, H. R., Trung, N. V., Pham, H. V., Subekti, D., Harun, S., Malik, S., Robinson, J., et al. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000231 · Cited by 48
Averting the AMR crisis. What are the avenues for policy action for countries in Europe?
Anderson, M., Clift, C., Schulze, K., Sagan, A., Nahrgang, S. A., Ouakrim, D. A., & Mossialos, E. (2019) · Research Explorer (The University of Manchester) · doi:10.13140/rg.2.2.15022.36160 · Cited by 42
Understanding Rifampicin Resistance in Tuberculosis through a Computational Approach
Kumar, S., & Jena, L. (2014) · Genomics & Informatics · doi:10.5808/gi.2014.12.4.276 · Cited by 40
Production of Pseudomonas aeruginosa Intercellular Small Signaling Molecules in Human Burn Wounds
Que, Y., Hazan, R., Ryan, C. M., Milot, S. M., Lepine, F. L., Lydon, M. K., & Rahme, L. G. (2011) · Journal of Pathogens · doi:10.4061/2011/549302 · Cited by 24
Parumasivam, T., Kumar, H. S. N., Ibrahim, P., Sadikun, A., & Mohamad, S. (2013) · Journal of Pharmacy Research · doi:10.1016/j.jopr.2013.04.039 · Cited by 13
Self-citation
Cited by
Fu, Y., Dou, Q., Smalla, K., Wang, Y., Johnson, T. A., Brandt, K. K., Mei, Z., Liao, M., Hashsham, S. A., Schäffer, A., et al. (2023) · mLife · doi:10.1002/mlf2.12101 · Cited by 65
Metaproteomics in the One Health framework for unraveling microbial effectors in microbiomes
Heyer, R., Wolf, M., Benndorf, D., Uzzau, S., Seifert, J., Grenga, L., Pabst, M., Schmitt, H., Mesuere, B., Van Den Bossche, T., et al. (2025) · Microbiome · doi:10.1186/s40168-025-02119-5 · Cited by 22
de Souza, A. Á., Lima, A. M., dede Oliveira BezerraSousa, D., Nogueira, F. C., do Sacramento Neto, J. C., Dias, L. P., Araújo, N. M. S., Nagano, C. S., Júnior, H. V. N., da Silva, C. R., et al. (2023) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-022-09979-5 · Cited by 8
(2023) · doi:10.1002/prot.26504 · Cited by 2
Gaber, H. S., Saied, E., & Mahdy, H. M. (2025) · Al-Azhar Bulletin of Science · doi:10.58675/2636-3305.1698 · Cited by 1
Metadata
- Authors
- Pulingam, T., Parumasivam, T., Gazzali, A. M., Sulaiman, A. M., Chee, J. Y., Lakshmanan, M., Chin, C. F., & Sudesh, K.
- Venue
- European Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2022-03
- Volume
- 170
- Pages
- 106103
- ISSN
- 0928-0987 (ISSN-L)
- OpenAlex
- W4200064404
- Cited by
- 550
- References
- 90
- FWCI
- 38.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.